News for Medical Developments International Limited (MVP.AX)

Apr 29, 2024 / 01:30AM GMTBrent MacGregor Medical Developments International Limited-CEO Thank you and good morning, and welcome to today's investor briefing. T

Revenue: Up 3% year-over-year.Gross Margin: Improved by 5 percentage points to 74%.Underlying EBIT: Improved by $7 million.Free Cash Flow: Improved by $10 mill

Aug 31, 2023 / 12:00AM GMTOperator Thank you for standing by, and welcome to the Medical Developments International FY 2023 full year results conference call. (

Feb 24, 2022 / 11:00PM GMTGordon Naylor - Medical Developments International Limited - Chairman Okay. So good morning, everyone, and welcome to the investor bri

Feb 29, 2024 / 12:00AM GMTOperator Thank you for standing by, and welcome to the Medical Developments International FY24 half year results. (Operator instructio

All Ordinaries Index dips but select microcap ASX shares soar

Incannex Healthcare Inc (IXHL) has experienced a remarkable surge in its stock price, with an 800.00% gain over the past week and an impressive 519.15% increase

Incannex Healthcare Inc (IXHL) has experienced a remarkable surge in its stock price, with a 768.48% gain over the past week and an impressive 451.03% gain over

Long-awaited US approval for MVP's Penthrox 'green whistle' closer; Imricor establishes first iCMR lab at the University Hospital Lausanne.

Medical Developments International (ASXLMVP) has scrapped plans for clinical trials of its Penthrox drug in China.

Read Medical Developments International Limited (ASX:MVP) Insider Acquires A$33,954.47 in Stock at ETF Daily News

What's Gavin Wendt watching in the mining fire sale, why Israel does tech stocks better, and renewables breaks records.

onlyGreen Whistle gets the Green Light useInvestor Presentation Gordon Naylor - Chair Brent MacGregor - CEO ersonal3... | March 2, 2022

onlyMVP FY22 Half Year Results & Investor Presentation Gordon Naylor - Chair Brent MacGregor - CEO use25 February 2022 10am AEDT ... | February 24, 2022

Alloggio Group (ASX:ALO), didn't have a positive debut on the ASX last week but that didn't stop one director from buying more on market.